Further data on autologous haemopoietic stem cell transplantation in multiple sclerosis

The Lancet Neurology

Volumn 8, Issue 3, 2009, Pages 219-221

  Mancardi, Gianluigi ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GADOLINIUM; GLATIRAMER; INTERFERON; MELPHALAN; MITOXANTRONE; NATALIZUMAB; STEROID; THYMOCYTE ANTIBODY;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; COGNITION; DERMATOMAL ZOSTER; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEBRILE NEUTROPENIA; HEMORRHAGIC CYSTITIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MORTALITY; MULTIPLE SCLEROSIS; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; RELAPSE; REMISSION; SINGLE DRUG DOSE; SKIN DISEASE; TREATMENT RESPONSE;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS;

EID: 60049098999     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70018-3     Document Type: Letter

References (9)

1. Mancardi G., and Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 7 (2008) 626-636
2. Burt R.K., Loh Y., Cohen B., et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relasping-remitting multiple sclerosis: a phase I/II study. Lancet Neurol (2009) 10.1016/S1474-4422(09)70017-1 published online January 30.
3. Mancardi G.L., Murialdo A., Rossi P., et al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 11 (2005) 367-371
4. Portaccio E., Amato M.P., Siracusa G., et al. Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases. Mult Scler 13 (2007) 676-678
5. Kimiskidis V., Sakellari I., Tsimourtou V., et al. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome. Mult Scler 14 (2008) 278-283
6. Fagius J., Lundgren J., and Oberg G. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler (2008) 10.1177/1352458508096875 published online Sept 19.
7. Shevchenko Y.L., Novik A.A., Kuznetsov A.N., et al. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis. Exp Hematol 36 (2008) 922-928
8. The CAMMS223 trial investigators. Alemtuzumab vs. inteferon beta-1a in early multiple sclerosis. N Engl J Med 359 (2008) 1786-1801
9. Muraro P.A., Douek D.C., Packer A., et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 201 (2005) 805-816